Addition of GM-CSF to Fludarabine-containing Regimens in Chronic Lymphocytic Leukemia and Indolent non-Hodgkin Lymphoma

Conclusion GM-CSF-based chemo-immunotherapy was well-tolerated and resulted in a high response rate and warrants evaluation if larger studies.
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research